LIFECORE BIOMEDICAL, INC. DE (LFCR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 05-25. Amounts in USD.

Revenue Quarterly

0 60M 120M 180M Q4 '16: 135.3M Q1 '17: 109.1M Q2 '17: 110.2M Q3 '17: 129.3M Q4 '17: 121.3M Q1 '18: 115.8M Q2 '18: 122.5M Q3 '18: 144.9M Q4 '18: 141.1M Q1 '19: 124.7M Q2 '19: 124.6M Q3 '19: 155.6M Q4 '19: 152.8M Q1 '20: 138.7M Q2 '20: 142.6M Q3 '20: 152.9M Q4 '20: 156.1M Q1 '21: 135.6M Q2 '21: 130.9M Q3 '21: 44.7M Q4 '21: 44.9M Q1 '22: 41.6M Q2 '22: 43.5M Q3 '22: 37.4M Q4 '22: 28.1M Q1 '23: 23.7M Q2 '23: 21.9M Q3 '23: 26.5M Q4 '23: 31.1M Q1 '24: 24.5M Q2 '24: 30.1M Q3 '24: 35.7M Q4 '24: 37.9M Q1 '25: 24.7M Q2 '25: 32.6M Q3 '25: 35.2M Q4 '25: 36.4M Q2 '26: 31.1M Q4 '26: 23.2M Q1 '27: 34.2M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q1 '27

Gross Profit Quarterly

0 9M 18M 27M Q4 '16: 18.6M Q1 '17: 21.1M Q2 '17: 19M Q3 '17: 23.4M Q4 '17: 19.1M Q1 '18: 18.8M Q2 '18: 14.9M Q3 '18: 19.8M Q4 '18: 24.8M Q1 '19: 16.3M Q2 '19: 16.9M Q3 '19: 21.6M Q4 '19: 26.2M Q1 '20: 15.3M Q2 '20: 15.5M Q3 '20: 20M Q4 '20: 24.1M Q1 '21: 16.3M Q2 '21: 20.6M Q3 '21: 14.4M Q4 '21: 14.6M Q1 '22: 10.4M Q2 '22: 14.7M Q3 '22: 12.9M Q4 '22: 10.4M Q1 '23: 6M Q2 '23: 5.7M Q3 '23: 8.5M Q4 '23: 7.8M Q1 '24: 2.7M Q2 '24: 10M Q3 '24: 11.9M Q4 '24: 17.3M Q1 '25: 5.4M Q2 '25: 11.1M Q3 '25: 9.8M Q4 '25: 14M Q2 '26: 7.8M Q4 '26: 4.5M Q1 '27: 12.1M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q1 '27

Operating Income Quarterly

-18M -12M -6M 0 6M 12M 18M Q4 '16: 6.3M Q1 '17: 5.5M Q2 '17: 3.3M Q3 '17: 4.3M Q4 '17: 1.6M Q1 '18: 2.7M Q2 '18: -695K Q3 '18: 3.5M Q4 '18: 8.1M Q1 '19: -257K Q2 '19: 10K Q3 '19: 3.2M Q4 '19: 2.5M Q1 '20: -4.4M Q2 '20: -6M Q3 '20: -15M Q4 '20: -449K Q1 '21: -12.5M Q2 '21: -1.5M Q3 '21: 2.4M Q4 '21: 2.7M Q1 '22: -2.7M Q2 '22: 4.1M Q3 '22: -8.6M Q4 '22: -2.6M Q1 '23: -3.3M Q2 '23: -5.4M Q3 '23: -6.5M Q4 '23: -6.6M Q1 '24: -8.6M Q2 '24: -1.5M Q3 '24: -895K Q4 '24: 2.1M Q1 '25: -11.6M Q2 '25: -2M Q3 '25: -9M Q4 '25: 5.3M Q2 '26: -3.1M Q4 '26: -4.7M Q1 '27: 2.6M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q1 '27

Net Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q4 '16: 4.7M Q1 '17: 3.3M Q2 '17: 1.3M Q3 '17: 3.5M Q4 '17: 2.5M Q1 '18: 2.1M Q2 '18: 487K Q3 '18: 16.1M Q4 '18: 6.1M Q1 '19: 190K Q2 '19: -585K Q3 '19: 1.1M Q4 '19: -262K Q1 '20: -4.8M Q2 '20: -6.7M Q3 '20: -11.5M Q4 '20: -15.1M Q1 '21: -11M Q2 '21: -13.3M Q3 '21: -5.5M Q4 '21: -1.3M Q1 '22: -9.5M Q2 '22: -38.5M Q3 '22: -13.1M Q4 '22: -55.3M Q1 '23: -11M Q2 '23: -12.8M Q3 '23: -36.5M Q4 '23: -39.3M Q1 '24: -10.8M Q2 '24: 14.2M Q3 '24: 15.6M Q4 '24: -7.1M Q1 '25: -16.2M Q2 '25: -6.6M Q3 '25: -14.8M Q4 '25: -1.1M Q2 '26: -10M Q4 '26: -15M Q1 '27: -6.2M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q1 '27

Cost of Revenue Quarterly

0 50M 100M 150M Q4 '12: 67.9M Q1 '13: 88.3M Q2 '13: 96.2M Q3 '13: 100.4M Q4 '13: 94.1M Q1 '14: 96.9M Q2 '14: 106.3M Q3 '14: 106.2M Q1 '18: 97M Q2 '18: 107.5M Q3 '18: 125.1M Q4 '18: 116.3M Q1 '19: 108.3M Q2 '19: 107.7M Q3 '19: 134M Q4 '19: 126.6M Q1 '20: 123.4M Q2 '20: 127.1M Q3 '20: 132.9M Q1 '21: 119.3M Q2 '21: 110.3M Q3 '21: 30.2M Q1 '22: 31.2M Q2 '22: 28.7M Q3 '22: 24.5M Q1 '23: 17.7M Q2 '23: 16.2M Q3 '23: 18M Q4 '23: 23.4M Q1 '24: 21.8M Q2 '24: 20.2M Q3 '24: 23.8M Q4 '24: 20.6M Q1 '25: 19.3M Q2 '25: 21.5M Q3 '25: 25.3M Q4 '25: 22.5M Q2 '26: 23.3M Q4 '26: 18.7M Q1 '27: 22.1M Q4 '13 Q2 '18 Q3 '19 Q1 '21 Q3 '22 Q1 '24 Q2 '25 Q1 '27

Operating Cash Flow Quarterly

-20M -10M 0 10M 20M 30M Q2 '16: 4M Q3 '16: 4.1M Q4 '16: 15.5M Q1 '17: 10M Q2 '17: 9.7M Q3 '17: 26.6M Q4 '17: 6.7M Q1 '18: 3.5M Q2 '18: 6.3M Q3 '18: 20.3M Q4 '18: -521K Q1 '19: 2.2M Q2 '19: 2.6M Q3 '19: 12.6M Q1 '20: -5.4M Q2 '20: -9.5M Q3 '20: 10.6M Q4 '20: -12.7M Q1 '21: 17M Q2 '21: 1.2M Q3 '21: -7.1M Q4 '21: 5.3M Q1 '22: 831K Q2 '22: -4.8M Q3 '22: -17.3M Q4 '22: -1.9M Q1 '23: -1.1M Q2 '23: -2.4M Q3 '23: -11.7M Q4 '23: -2.3M Q1 '24: -8.3M Q2 '24: 1.3M Q3 '24: -1.4M Q1 '25: -613K Q2 '25: -6.1M Q3 '25: 1.2M Q4 '25: 5.3M Q2 '26: 1.8M Q4 '26: 4.7M Q1 '27: -2.2M Q2 '17 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q2 '25 Q1 '27

Free Cash Flow Quarterly

-24M -16M -8M 0 8M 16M 24M Q4 '15: 5.9M Q1 '16: -5.3M Q2 '16: -7.7M Q3 '16: -6.8M Q4 '16: 2M Q1 '17: 7.8M Q2 '17: 7.1M Q3 '17: 21.9M Q4 '17: -6.9M Q1 '18: -2.3M Q2 '18: 2.6M Q3 '18: 9M Q4 '18: -13.4M Q1 '19: -12.3M Q2 '19: -1.5M Q3 '19: -1.9M Q1 '20: -15.4M Q2 '20: -15.5M Q3 '20: 4.5M Q1 '21: 12.4M Q2 '21: -1.6M Q3 '21: -11M Q4 '21: -2.6M Q1 '22: -7.1M Q2 '22: -9.9M Q3 '22: -22.8M Q4 '22: -9.5M Q1 '23: -4.5M Q2 '23: -6.2M Q3 '23: -18.8M Q1 '24: -13.4M Q2 '24: -3M Q3 '24: -7.8M Q1 '25: -4M Q2 '25: -8.6M Q3 '25: -4.3M Q4 '25: 3.3M Q2 '26: 25K Q4 '26: 3.6M Q1 '27: -2.7M Q4 '16 Q1 '18 Q2 '19 Q1 '21 Q2 '22 Q3 '23 Q2 '25 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '14: 27.1M Q3 '14: 27.1M Q1 '15: 27.3M Q1 '15: 27.3M Q2 '15: 27.3M Q4 '15: 27.4M Q1 '16: 27.4M Q2 '16: 27.4M Q3 '16: 27.1M Q1 '17: 27.5M Q2 '17: 27.6M Q3 '17: 27.7M Q1 '18: 27.9M Q2 '18: 27.9M Q3 '18: 27.9M Q1 '19: 28M Q2 '19: 27.8M Q3 '19: 29.2M Q1 '20: 29.1M Q2 '20: 29.2M Q3 '20: 29.2M Q1 '21: 29.2M Q2 '21: 29.3M Q3 '21: 29.3M Q1 '22: 29.4M Q2 '22: 29.5M Q3 '22: 29.5M Q1 '23: 29.6M Q2 '23: 29.6M Q3 '23: 30.3M Q1 '24: 30.4M Q2 '24: 36.4M Q3 '24: 36.6M Q1 '25: 30.9M Q2 '25: 34.4M Q3 '25: 37M Q4 '25: 37M Q2 '26: 37.4M Q4 '26: 37.5M Q1 '27: 37.6M Q2 '15 Q1 '17 Q3 '18 Q2 '20 Q1 '22 Q3 '23 Q2 '25 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q1 '16: 0.52 Q2 '16: 0.47 Q3 '16: -0.45 Q4 '16: -0.43 Q1 '17: -0.42 Q2 '17: -0.44 Q3 '17: 0.47 Q4 '17: 0.39 Q1 '18: 0.35 Q2 '18: 0.32 Q3 '18: 0.76 Q4 '18: 0.89 Q1 '19: 0.82 Q2 '19: 0.78 Q3 '19: 0.25 Q4 '19: 0.01 Q1 '20: -0.16 Q2 '20: -0.37 Q3 '20: -0.80 Q4 '20: -1.30 Q1 '21: -1.52 Q2 '21: -1.74 Q3 '21: -1.54 Q4 '21: -1.06 Q1 '22: -1.00 Q2 '22: -1.85 Q3 '22: -2.11 Q4 '22: -3.95 Q1 '23: -4.00 Q2 '23: -3.13 Q3 '23: -3.88 Q4 '23: -3.32 Q1 '24: -3.30 Q2 '24: -2.48 Q3 '24: -0.86 Q4 '24: 0.33 Q1 '25: 0.15 Q2 '25: -0.49 Q3 '25: -1.33 Q4 '25: -1.26 Q1 '17 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.